Replies to post #671 on Moleculin Biotech Inc (MBRX)

[king oil]

I'm not sure why the company hasn't issued a press release on this good news.

On November 29, 2017, Moleculin Biotech, Inc. (the “Company”) was informed that the physician-sponsored Investigational New Drug application made by MD Anderson Cancer Center for a Phase I trial of the Company's licensed drug compound WP1066 in patients with recurrent malignant glioma and brain metastasis from melanoma has been allowed by the U.S. Food and Drug Administration.

[wagthewhale]

8k http://archive.fast-edgar.com//20171204/AOZ2322CZ22272Z2222D22ZZB68SNP7R8292/